<clinical_study>
  <!-- This xml conforms to an XML Schema at:
    https://clinicaltrials.gov/ct2/html/images/info/public.xsd -->
  <required_header>
    <download_date>ClinicalTrials.gov processed this data on November 19, 2021</download_date>
    <link_text>Link to the current ClinicalTrials.gov record.</link_text>
    <url>https://clinicaltrials.gov/show/NCT04917419</url>
  </required_header>
  <id_info>
    <org_study_id>2020-A02526-33</org_study_id>
    <nct_id>NCT04917419</nct_id>
  </id_info>
  <brief_title>Nursing Care of Bipolar Patients With Sleeping Disorders Using Luminotherapy and /or Psychoeducation Program (BIPLUMINO)</brief_title>
  <acronym>BIPLUMINO</acronym>
  <official_title>Prise en Charge infirmière Des Anomalies du Sommeil et du Rythme Circadien Par luminothérapie et/ou un Programme Court de psychoéducation Chez Des Patients Souffrant de Troubles Bipolaires</official_title>
  <sponsors>
    <lead_sponsor>
      <agency>Centre Hospitalier Henri Laborit</agency>
      <agency_class>Other</agency_class>
    </lead_sponsor>
  </sponsors>
  <source>Centre Hospitalier Henri Laborit</source>
  <oversight_info>
    <has_dmc>No</has_dmc>
    <is_fda_regulated_drug>No</is_fda_regulated_drug>
    <is_fda_regulated_device>No</is_fda_regulated_device>
  </oversight_info>
  <brief_summary>
    <textblock>
      Bipolar disorder affects more than 1% of the population. This pathology is considered as one&#xD;
      of the most serious psychiatric disorder because of it is high suicide rates. It impacts&#xD;
      patients life quality on many aspects, and specially their sleeping and circadian Rhythms.&#xD;
      This can lead to more severe symptoms up to for thymic relapses. It was shown that&#xD;
      Luminotherapy and Psychoeducation Program have a positive impact on these type of symptoms.&#xD;
    </textblock>
  </brief_summary>
  <overall_status>Not yet recruiting</overall_status>
  <start_date type="Anticipated">September 2021</start_date>
  <completion_date type="Anticipated">December 2024</completion_date>
  <primary_completion_date type="Anticipated">June 2024</primary_completion_date>
  <phase>N/A</phase>
  <study_type>Interventional</study_type>
  <has_expanded_access>No</has_expanded_access>
  <study_design_info>
    <allocation>Randomized</allocation>
    <intervention_model>Parallel Assignment</intervention_model>
    <primary_purpose>Supportive Care</primary_purpose>
    <masking>None (Open Label)</masking>
  </study_design_info>
  <primary_outcome>
    <measure>Number of days in-hospital</measure>
    <time_frame>Day 0 to Day 365</time_frame>
    <description>Number of days patients spent in the hospital</description>
  </primary_outcome>
  <number_of_arms>2</number_of_arms>
  <enrollment type="Anticipated">170</enrollment>
  <condition>Bipolar Disorder</condition>
  <arm_group>
    <arm_group_label>Luminotherapy and Psychoeducation Program</arm_group_label>
    <arm_group_type>Experimental</arm_group_type>
  </arm_group>
  <arm_group>
    <arm_group_label>Psychoeducation Program</arm_group_label>
    <arm_group_type>Active Comparator</arm_group_type>
  </arm_group>
  <intervention>
    <intervention_type>Other</intervention_type>
    <intervention_name>Luminotherapy and /or Psychoeducation Program</intervention_name>
    <description>TO complete</description>
    <arm_group_label>Luminotherapy and Psychoeducation Program</arm_group_label>
    <arm_group_label>Psychoeducation Program</arm_group_label>
  </intervention>
  <eligibility>
    <criteria>
      <textblock>
        Main inclusion Criteria:&#xD;
&#xD;
          -  Bipolar disorder (type 1 and 2 according to DSM V)&#xD;
&#xD;
          -  Mood Disorder Questionnaire MDQ ˂ 7&#xD;
&#xD;
          -  Sleeping and Circadian Rhythms Disorders&#xD;
&#xD;
          -  Under treatment&#xD;
&#xD;
        Main exclusion Criteria:&#xD;
&#xD;
          -  No addiction except for tobacco&#xD;
&#xD;
          -  Narcolepsy&#xD;
&#xD;
          -  Sleep Apnea&#xD;
&#xD;
          -  Psychiatric comorbidities&#xD;
&#xD;
          -  Suicidal ideation&#xD;
      </textblock>
    </criteria>
    <gender>All</gender>
    <minimum_age>18 Years</minimum_age>
    <maximum_age>65 Years</maximum_age>
    <healthy_volunteers>No</healthy_volunteers>
  </eligibility>
  <overall_contact>
    <last_name>Cécile BOISVERT</last_name>
    <phone>0033 5 16 52 61 18</phone>
    <email>cecile.boisvert@ch-poitiers.fr</email>
  </overall_contact>
  <verification_date>July 2021</verification_date>
  <study_first_submitted>February 26, 2021</study_first_submitted>
  <study_first_submitted_qc>June 7, 2021</study_first_submitted_qc>
  <study_first_posted type="Actual">June 8, 2021</study_first_posted>
  <last_update_submitted>July 28, 2021</last_update_submitted>
  <last_update_submitted_qc>July 28, 2021</last_update_submitted_qc>
  <last_update_posted type="Actual">July 29, 2021</last_update_posted>
  <responsible_party>
    <responsible_party_type>Sponsor</responsible_party_type>
  </responsible_party>
  <condition_browse>
    <!-- CAUTION:  The following MeSH terms are assigned with an imperfect algorithm            -->
    <mesh_term>Bipolar Disorder</mesh_term>
  </condition_browse>
  <patient_data>
    <sharing_ipd>No</sharing_ipd>
  </patient_data>
  <!-- Results have not yet been posted for this study                                          -->
</clinical_study>

